URGN
UroGen Pharma Ltd. Ordinary Shares
$38.24
-6.94%
-2.85
Notify me if price changes either direction
Buy URGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.9B
Enterprise value
2.0B
Trailing PE
-11.97492186926
Forward PE
27.380754
PEG Ratio
0.24482062488265
Enterprise to EBITDA
-18.791
Enterprise to revenue
14.432
Price to book MRQ
-15.428049172949
Price to sales TTM
14.183751
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
140.5M
EBITDA
-107902000
Diluted EPS TTM
-2.74
Total Cash (MRQ)
140.3M
Current ratio (MRQ)
4.69
Operating Cash Flow (TTM)
-165736000
URGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
